Eli Lilly (LLY) Gets Additional 6-Months of Cymbalta Pediatric Exclusivity
Tweet Send to a Friend
Eli Lilly and Company (NYSE: LLY) announced today that it has met the United States Food and Drug Administration (FDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE